Orphans and babies as young as three months old have been used as guinea pigs in potentially dangerous medical experiments sponsored by a giant pharmaceutical company.
British giant GlaxoSmithKline is embroiled in the scandal.
The firm sponsored experiments on the children from Incarnation Children's Center, a New York care home that specializes in treating HIV sufferers and is run by Catholic charities.
The children had either been infected with HIV or born to HIV-positive mothers.
Their parents were dead, untraceable or deemed unfit to look after them.
According to documents, Glaxo has sponsored at least four medical trials since 1995 using Hispanic and black children at Incarnation.
The documents give details of all clinical trials in the US and reveal that the experiments sponsored by Glaxo were designed to test the "safety and tolerance" of AIDS medications, some of which have potentially dangerous side effects.
Glaxo manufactures a number of drugs designed to treat HIV, including AZT.
Normally, trials on children would require parental consent but, as the infants are in care, New York's authorities hold that role.
The city health department has launched an investigation into claims that more than 100 children at Incarnation were used in 36 experiments -- at least four of them co-sponsored by Glaxo.
Some of these trials were designed to test the "toxicity" of AIDS medications.
One involved giving children as young as 4 years old a high-dosage cocktail of seven drugs at one time.
Another looked at the reaction in six-month-old babies to a double dose of measles vaccine.
Most experiments were funded by federal agencies like the National Institute of Allergy and Infectious Diseases.
Until now Glaxo's role had not emerged.
In 1997 an experiment co-sponsored by Glaxo used children from Incarnation to "obtain tolerance, safety and pharmacokinetic" data for herpes drugs.
In a more recent experiment, the children were used to test the drug AZT.
A third experiment sponsored by Glaxo and US drug firm Pfizer investigated the "long-term safety" of anti-bacterial drugs on three-month-old babies.
The medical establishment has defended the trials, arguing they enabled these children to obtain state-of-the-art therapy that they would otherwise not have received for illnesses that could potentially be fatal.
However, health campaigners argue there is a difference between providing the latest drugs and experimentation.
They claim many of the experiments were "phase 1 trials" -- among the most risky.
They also claim that HIV tests for babies are not a reliable indicator of actual infection and therefore toxic drugs could have been given to healthy infants. HIV drugs are similar to those used in chemotherapy and can have serious side effects.
Vera Sharav, president of the Alliance for Human Research Protection, said the children had been treated like "laboratory animals."
"These are some of the most vulnerable individuals in the country and there appears to be a policy of giving drug firms access to them," she said.
"Throughout the history of medical research we have seen prisoners abused, the mentally ill abused and now poor kids in a care home," she said.
Sharav has urged the US Food and Drug Administration to investigate and has demanded complete disclosure of all adverse effects suffered by the children, including deaths.
Glaxo has confirmed it provided funds for some of the experiments but denied any improper action.
A spokeswoman said, "These studies were implemented by the US AIDS Clinical Trial Group, a clinical research network paid for by the National Institutes of Health.
"Glaxo's involvement in such studies would have been to provide study drugs or funding but we would have no interactions with the patients.
"Generally speaking, clinical research is carefully regulated in the US and it would be the responsibility of the appropriate authorities to ensure all subjects in a clinical trial provided appropriate, informed consent to conform with all local laws and regulations regarding legal authority in the case of minors."
The Incarnation trials were run by Columbia University Medical Center doctors.
Columbia spokeswoman Annie Bayne said there had been no clinical trials at Incarnation since 2000 and that consent for the children was provided by the Administration for Children's Services, which relies on a panel of doctors and lawyers to determine whether the benefits of a trial for each child outweighs the risks to the child.
"There are many safeguards in the system. HIV is eventually a fatal disease, but drug therapy has lengthened life significantly," Bayne said.
A spokesman for Incarnation said regarding the scandal, "The purpose of the trials was to test the efficacy of HIV medication."
"These trials were based on scientific evidence of their potential value in the treatment of HIV- infected children," the spokesman said.
Young women standing idly around a park in Tokyo’s west suggest that a giant statue of Godzilla is not the only attraction for a record number of foreign tourists. Their faces lit by the cold glow of their phones, the women lining Okubo Park are evidence that sex tourism has developed as a dark flipside to the bustling Kabukicho nightlife district. Increasing numbers of foreign men are flocking to the area after seeing videos on social media. One of the women said that the area near Kabukicho, where Godzilla rumbles and belches smoke atop a cinema, has become a “real
Two Belgian teenagers on Tuesday were charged with wildlife piracy after they were found with thousands of ants packed in test tubes in what Kenyan authorities said was part of a trend in trafficking smaller and lesser-known species. Lornoy David and Seppe Lodewijckx, two 19-year-olds who were arrested on April 5 with 5,000 ants at a guest house, appeared distraught during their appearance before a magistrate in Nairobi and were comforted in the courtroom by relatives. They told the magistrate that they were collecting the ants for fun and did not know that it was illegal. In a separate criminal case, Kenyan Dennis
Incumbent Ecuadoran President Daniel Noboa on Sunday claimed a runaway victory in the nation’s presidential election, after voters endorsed the young leader’s “iron fist” approach to rampant cartel violence. With more than 90 percent of the votes counted, the National Election Council said Noboa had an unassailable 12-point lead over his leftist rival Luisa Gonzalez. Official results showed Noboa with 56 percent of the vote, against Gonzalez’s 44 percent — a far bigger winning margin than expected after a virtual tie in the first round. Speaking to jubilant supporters in his hometown of Olon, the 37-year-old president claimed a “historic victory.” “A huge hug
A judge in Bangladesh issued an arrest warrant for the British member of parliament and former British economic secretary to the treasury Tulip Siddiq, who is a niece of former Bangladeshi prime minister Sheikh Hasina, who was ousted in August last year in a mass uprising that ended her 15-year rule. The Bangladeshi Anti-Corruption Commission has been investigating allegations against Siddiq that she and her family members, including Hasina, illegally received land in a state-owned township project near Dhaka, the capital. Senior Special Judge of Dhaka Metropolitan Zakir Hossain passed the order on Sunday, after considering charges in three separate cases filed
RSS